In her latest I am BIO Podcast, BIO President and CEO Dr. Michelle McMurry-Heath speaks with three guests who are fighting to bend the trajectory of Alzheimer’s disease.
There’s no cure for Alzheimer’s disease—which is expected to reach a $1 trillion economic burden in the U.S. as the population ages.
But now, there’s hope—including more investment in R&D, the approval of a new treatment, an experimental gene therapy, and even a potential vaccine that slowed disease progression by 50% in a clinical trial.
Dr. Michelle McMurry-Heath learns more from her guests:
- Maria Carrillo, Chief Science Officer of the Alzheimer’s Association’s Global Research Program
- Nolan Townsend, CEO of Lexeo Therapeutics
- Mei Mei Hu, Co-Founder, President & CEO of Vaxxinity
